AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...

Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...

A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...

The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis with ...

Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

Purpose The evidence evaluating the efficacy of i.v. versus oral iron for the treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease (CKD) is reviewed.

Treating chronic disease has proven difficult because there is not one simple cause, like a single gene mutation, that a treatment could target. At least, that's how it has appeared to scientists ...

and the number of people with such diseases is growing. Treating chronic disease has proven difficult because there is not one simple cause, like a single gene mutation, that a treatment could target.

The world of health devices and therapy is evolving faster than ever and 2024 is shaping up to be a groundbreaking year From wearable tech that monitors your vitals in real time to cutting-edge therap ...